Melhores Tumores neuroendócrinos pancreáticos Tumores neuroendócrinos pancreáticos em Israel - TOP-19 médicos

A Dra. Pelles Sharon é especialista em tumores neuroendócrinos pancreáticos, oferecendo tratamentos avançados como a cirurgia de Whipple e HIPEC no Sourasky Medical Center.

• Ter experiência em uma ampla gama de cirurgias e terapias oncológicas
• Realizar pesquisas clínicas para melhorar a compreensão dos pacientes sobre os ensaios
• Fornecer planos de tratamento personalizados, incluindo imunoterapia e terapia-alvo

O Prof. Merimsky lidera a Unidade de Oncologia de Tecidos Moles e Óseos no Sourasky Medical Center – o maior programa de sarcoma de Israel.

• Mais de 25 anos de especialização em tumores neuroendócrinos
• Membro do corpo docente da ESMO para tratamento de sarcomas
• Especialização realizada no Institut Gustave Roussy em Paris
• Vastas publicações sobre tratamentos de tumores raros

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Chefia a Divisão de Oncologia Médica no Sourasky Medical Center de Israel – um dos principais hospitais universitários do país.

• Especializar-se em medicina interna e oncologia médica no Sheba Medical Center
• Possuir um diploma da Universidade Ben Gurion do Negev
• Falar inglês fluente, facilitando consultas internacionais

Líder da Iniciativa Nacional de Medicina Genómica de Israel – Dr. Raphael é especialista em perfis genómicos avançados para tumores neuroendócrinos pancreáticos no Sourasky Medical Center.

• Professor sénior na Faculdade de Medicina da Universidade de Tel Aviv
• Investigador principal de múltiplos ensaios clínicos em oncologia
• Especialista em biópsias líquidas e perfis genómicos tumorais abrangentes
• Membro da European Society of Medical Oncology e da IASLC

Chefe do Departamento de Cirurgia Colorretal do Sourasky Medical Center – um dos principais especialistas na cirurgia de Whipple para tumores neuroendócrinos pancreáticos.

• Mais de 20 anos de experiência como cirurgião abdominal
• Realizar procedimentos cirúrgicos abertos e minimamente invasivos
• Especialista na técnica complexa de Whipple (pancreatoduodenectomia)

Irina Stepfansky é a diretora de internação oncológica no Centro Médico de Tel Aviv (Ichilov) – um hospital líder com acreditação JCI em Israel.

• Mais de 25 anos de experiência médica desde o início da prática
• Formação especializada em oncologia no proeminente departamento do Ichilov
• Trabalhar como investigadora principal em ensaios clínicos de fase I-III para novos medicamentos oncológicos
• Certificação oficial tanto em medicina interna quanto em oncologia clínica

Um dos melhores cirurgiões de Whipple em Israel, o Dr. Klauzner chefia o Departamento de Cirurgia do Sourasky Medical Center.

• Mais de 45 anos de experiência cirúrgica
• Especializar-se em procedimentos colorretais e pancreáticos complexos
• Vasta experiência em cirurgia de cancro gastrointestinal
• Liderar uma equipa cirúrgica de topo num grande hospital de Tel Aviv

A Dra. Inna Ospovat é uma especialista líder em PRRT com Lutécio-177, pioneira mundial nesta terapia inovadora.

• Chefiar o departamento de terapia nuclear no Ichilov – um dos poucos centros que oferece este tratamento
• Especializar-se em oncologia e radioterapia no Hospital Universitário Hadassah
• Membro da ASTRO e da Sociedade de Oncologia Clínica de Israel
• Especialista em tratamentos radiobiológicos para tumores gastrointestinais

A Dra. Ayala Hubert é chefe do Centro de Cancro Gastrointestinal do Hadassah Medical Center – especializada em cancros do sistema digestivo.

• 33 anos de experiência como oncologista médica e radioterapeuta
• Formação em psicologia na Universidade Hebraica – confere um toque humano aos cuidados oncológicos
• Certificada pela ordem tanto em Oncologia como em Radioterapia
• Membro ativo do Comité de Israel para o Cancro Gastrointestinal

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.